Serabelisib (INK-1117,MLN-1117,TAK-117)
Serabelisib (INK-1117,MLN-1117,TAK-117) is a potent and selective oral PI3K? isoform inhibitor (IC50 of 21 nmol/L against PI3K?) that has demonstrated > 100-fold selectivity relative to other class I PI3K family members (PI3K?/?/?) and mTOR, and a high degree of selectivity against many other kinase.
